Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Motomi Nakata is active.

Publication


Featured researches published by Motomi Nakata.


Advances in Immunology | 1992

Role of Perforin in Lymphocyte-Mediated Cytolysis

Hideo Yagita; Motomi Nakata; Akemi Kawasaki; Yoichi Shinkai; K Okumura

Publisher Summary This chapter discusses structure and expression of perforin. Perforin is a primary candidate as mediator of the cellular cytotoxicity exhibited by cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. The granule exocytosis model of lymphocyte-mediated cytolysis, wherein perforin is expected to play a central role, has been proposed on the basis of a great deal of circumstantial evidence. The central role of perforin and universality of the granule exocytosis model have been challenged based on evidence that some CTLs apparently lacking perforin expression are found and that some CTLs and lymphokine-activated killer cells lysed certain target cells without apparent granule exocytosis. The physiological relevance of the perforin-dependent and -independent pathways of lymphocyte-mediated cytolysis, mainly based on recent observations is discussed. The propriety of the perforin/granule exocytosis model has been challenged by extensive studies using various T cell clones, including classical CD8+ CTLs and recently characterized CD4+ helper/killer T cells. Perforin expression in primary CTLs in peritoneal exudate lymphocytes (PELS) after intraperitoneal immunization with allogeneic spleen cells is examined.


Immunology Letters | 1991

Interleukin-2 activated T cells (T-LAK) express CD16 antigen and are triggered to target cell lysis by bispecific antibody

Taizo Nitta; Motomi Nakata; Hideo Yagita; Ko Okumura

Human PBMCs from healthy donors were cultured with 100 U/ml rIL-2 for up to 5 weeks and tested at short and long activation times for the ability to mediate CD3 and CD16 targeted cytotoxicity using chemically cross-linked bispecific antibodies. At each period, LAK activity was augmented with the use of bispecific antibodies (BA), whereas interestingly enough, at later periods (4-5 weeks) when CD16 positive lymphocytes are not present by flow cytometry, CD16 targeted cytotoxicity was induced. We suspected the possibility of CD16 expression on activated T cells and have purified the T cell subpopulations to see the targeted cytotoxicity. Populations enriched for T cells by Percoll density centrifugation, treatment with anti-CD16 plus complement or sorting for CD5+ cells, were all able to mediate CD16 targeted cytotoxicity following activation with rIL-2. These data suggest that IL-2 activated T cells express CD16 in addition to CD3.


International Immunology | 1992

Expression of perforin and cytolytic potential of human peripheral blood lymphocyte subpopulations

Motomi Nakata; Akemi Kawasaki; Mlyuki Azuma; Kaori Tsuji; Hironori Matsuda; Yoichi Shinkai; Hideo Yagita; Ko Okumura


Archive | 1996

MONOCLONAL ANTIBODY REACTING SPECIFICALLY WITH Fas LIGAND AND PROCESS FOR PRODUCING THE SAME

Nobuhiko Kayagaki; Hideo Yagita; Kyoko Okumura; Motomi Nakata


Proceedings of the National Academy of Sciences of the United States of America | 1992

CD4 and CD8 regulate interleukin 2 responses of T cells.

Kaori Takahashi; Motomi Nakata; Toshiyuki Tanaka; Hiroyasu Adachi; Hiromitsu Nakauchi; Hideo Yagita; K Okumura


Archive | 1996

Monoclonal antibody reacting specifically reacting with Fas ligand and production process thereof

Nobuhiko Kayagaki; Hideo Yagita; Ko Okumura; Motomi Nakata


Archive | 1995

Method for quantitative determination of fas antigen

Kyoko Okumura; Hideo Yagita; Motomi Nakata; Hideo Arai


Archive | 2002

TRAF family molecules, polynucleotides encoding them, and antibodies against them

Motomi Nakata; Hiroyasu Nakano; Hideo Yagita; Ko Okumura


Archive | 1997

IMMUNOGLOBULINE HUMANISEE REAGISSANT SPECIFIQUEMENT AVEC UN LIGAND Fas OU L'UN DE SES FRAGMENTS ACTIFS ET REGION D'INDUCTION D'APOPTOSE PRENANT NAISSANCE DANS UN LIGAND Fas

Ko Okumura; Motomi Nakata; Hirofumi Higuchi; Yoshitaka Ushio; Hiroaki Maeda; Yasuyuki Eda


Archive | 1996

Monoklonaler antikörper, der spezifisch mit dem fas-liganden reagiert, und verfahren zu seiner herstellung A monoclonal antibody which specifically reacts with the Fas ligand, and method for its preparation

Nobuhiko Kayagaki; Hideo Yagita; Ko Okumura; Motomi Nakata

Collaboration


Dive into the Motomi Nakata's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ko Okumura

Sumitomo Electric Industries

View shared research outputs
Top Co-Authors

Avatar

Nobuhiko Kayagaki

Sumitomo Electric Industries

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hirofumi Higuchi

Sumitomo Electric Industries

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge